Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | ZYMEWORKS INC ZYME | Perceptive Advisors LLC | 4,511,275 7.200% | 4,511,275 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ENVVENO MED CORP COM NVNO | Perceptive Advisors LLC | 26,786 9.900% | -478 (-1.75%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | Perceptive Advisors LLC | 27,642,917 9.800% | 286,874 (+1.05%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | RAPT THERAPEUTICS INC RAPT | Perceptive Advisors LLC | 224,869 5.300% | -141,077 (-38.55%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | ARCELLX INC ACLX | Perceptive Advisors LLC | 2,598,305 5.500% | 2,598,305 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Perceptive Advisors LLC | 11,900,255 5.400% | -33,132 (-0.28%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | AGILE THERAPEUTICS INC AGRX | Perceptive Advisors LLC | 0 0.000% | -10,647 (Position Closed) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ALBIREO PHARMA INC ALBO | Perceptive Advisors LLC | 1,757,160 8.500% | -602,979 (-25.55%) | Filing History |
| 2023-02-14 2:31 pm Purchase | 2022-12-31 | 13G | VERU INC VERU | Perceptive Advisors LLC | 785,801 9.700% | 785,801 (New Position) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | Perceptive Advisors LLC | 2,617,691 4.200% | -2,232,221 (-46.03%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | COHERUS ONCOLOGY, INC. CHRS | Perceptive Advisors LLC | 0 0.000% | -5,407,798 (Position Closed) | Filing History |
| 2023-02-14 2:30 pm Sale | 2022-12-31 | 13G | LEAP THERAPEUTICS INC LPTX | Perceptive Advisors LLC | 672,650 6.800% | -175,000 (-20.65%) | Filing History |
| 2023-02-14 2:30 pm Purchase | 2022-12-31 | 13G | CINCOR PHARMA INC CINC | Perceptive Advisors LLC | 2,576,325 5.900% | 2,576,325 (New Position) | Filing History |
| 2023-02-14 2:30 pm Purchase | 2022-09-16 | 13G | LARIMAR THERAPEUTICS INC LRMR | Perceptive Advisors LLC | 2,860,000 6.600% | 2,860,000 (New Position) | Filing History |
| 2023-02-03 4:31 pm Unchanged | 2023-02-01 | 13D | SOLID BIOSCIENCES INC SLDB | Perceptive Advisors LLC | 3,501,265 17.900% | 0 (Unchanged) | Filing History |
| 2023-02-02 5:01 pm Purchase | 2023-02-01 | 13D | ATHENEX INC ATNX | Perceptive Advisors LLC | 776,623 9.900% | 100,000 (+14.78%) | Filing History |
| 2023-01-13 5:07 pm Unchanged | 2023-01-10 | 13D | LANDOS BIOPHARMA INC LABP | Perceptive Advisors LLC | 1,486,992 36.900% | 0 (Unchanged) | Filing History |
| 2022-12-21 4:30 pm Sale | 2022-12-19 | 13D | ASTRIA THERAPEUTICS INC ATXS | Perceptive Advisors LLC | 2,487,802 9.900% | -5,199,383 (-67.64%) | Filing History |
| 2022-12-06 4:30 pm Purchase | 2022-12-02 | 13D | SOLID BIOSCIENCES INC SLDB | Perceptive Advisors LLC | 3,501,265 17.900% | 2,603,762 (+290.11%) | Filing History |
| 2022-11-18 4:31 pm Purchase | 2022-11-17 | 13G | ACRIVON THERAPEUTICS INC ACRV | Perceptive Advisors LLC | 3,007,858 14.400% | 3,007,858 (New Position) | Filing History |